Epigenetic therapy
Epigenetic therapy has been studied in 2 papers since 2022: none in people yet, 2 reviews; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Aug 27, 2026: “Epigenetics in development, disease, and therapy: from mechanisms to clinical interventions”.
2 papers study it1 findingUpdated
- Funder: National Institute of Diabetes and Digestive and Kidney Diseases
What did studies of Epigenetic therapy find?
1Studies of Epigenetic therapy measured 1 outcome; the most studied are cellular senescence (1 study).
Cellular senescence
downin reviews1
1 study
Cellular senescence
downin reviews1
Epigenetic therapy decreases cellular senescence.
“epigenetic therapy based on aberrant epigenetic modifications could alleviate the senescence and dysfunction of stem cells”
Review
Epigenetic therapy targeting bone marrow mesenchymal stem cells for age-related bone diseases
Stem cell research & therapy
Funding
1 grant since 2018National Institute of Diabetes and Digestive and Kidney DiseasesUS$865k
Latest
1 paper in 12 monthsScience China Life Sciences
Epigenetics in development, disease, and therapy: from mechanisms to clinical interventions
ReviewMechanisms
Stem Cell Research & Therapy
Epigenetic therapy targeting bone marrow mesenchymal stem cells for age-related bone diseases
ReviewBones and joints